The Musculoskeletal Pain market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Musculoskeletal Pain: An Overview
Musculoskeletal pain affects the bones, muscles, ligaments, tendons, and nerves, with the pain ranging from mild to severe enough to interfere with day-to-day life. It may start suddenly and be short-lived, which is called acute pain. Pain that lasts for more time is called chronic pain. Musculoskeletal pain can be localized in one area,or widespread.
The most effective way to manage pain is with multidisciplinary pain management and the use of self-management. In a small number of cases, the condition may be improved with joint replacement surgery or the implantation of a spinal cord stimulator by a specially trained pain specialist.
Chronic musculoskeletal pain conditions are multifaceted, and approximately 20% of the adult population lives with severe chronic pain, with a higher prevalence in women and lower-income groups.
Musculoskeletal Pain Market Key Facts
-
According to the World Health Organization, while the prevalence of musculoskeletal conditions varies by age and diagnosis, between 20-33% of people across the globe live with a painful musculoskeletal condition.
-
According to DelveInsight, the total prevalent population of Musculoskeletal Pain in the 7 major markets was found to be 252,376,700+ in 2017.
-
Among the EU5 countries, the UK had the highest prevalent population of Musculoskeletal Pain, followed by Italy and Spain. On the other hand, France had the lowest prevalent Population.
-
In terms of gender, most of the patients diagnosed with Musculoskeletal Pain are female, as per DelveInsight assessments.
Increasing healthcare expenditure, rise in R&D activities, awareness among patients about the treatment options are expected to support the Musculoskeletal Pain market growth.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Musculoskeletal Pain market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Musculoskeletal Pain market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Musculoskeletal Pain Epidemiology
The epidemiology section covers insights into the historical and current Musculoskeletal Pain patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Musculoskeletal Pain Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Musculoskeletal Pain market or expected to get launched in the market during the study period. The analysis covers Musculoskeletal Pain market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Musculoskeletal Pain Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/musculoskeletal-pain-market
Musculoskeletal Pain Therapeutics Analysis
In the coming years, the competitive landscape for the Musculoskeletal Pain market is set to change due to rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market. Some of the key companies in the Musculoskeletal Pain market include:
Some of the companies in the Musculoskeletal Pain Market include:
-
Eli Lilly
-
Pfizer
-
Regeneron Pharmaceuticals
-
Mesoblast
-
Braeburn Pharmaceuticals
And many others.
Musculoskeletal Pain Therapies covered in the report include:
-
Tanezumab
-
Fasinumab
-
MPC-06-ID
-
CAM2038
And others
Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/musculoskeletal-pain-market
Table of Content
1. Key Insights
2. Executive Summary
3. Musculoskeletal Pain Competitive Intelligence Analysis
4. Musculoskeletal Pain Market Overview at a Glance
5. Musculoskeletal Pain Disease Background and Overview
6. Musculoskeletal Pain Patient Journey
7. Musculoskeletal Pain Epidemiology and Patient Population
8. Musculoskeletal Pain Treatment Algorithm, Current Treatment, and Medical Practices
9. Musculoskeletal Pain Unmet Needs
10. Key Endpoints of Musculoskeletal Pain Treatment
11. Musculoskeletal Pain Marketed Products
12. Musculoskeletal Pain Emerging Therapies
13. Musculoskeletal Pain Seven Major Market Analysis
14. Attribute Analysis
15. Musculoskeletal Pain Market Outlook (7 major markets)
16. Musculoskeletal Pain Access and Reimbursement Overview
17. KOL Views on the Musculoskeletal Pain Market.
18. Musculoskeletal Pain Market Drivers
19. Musculoskeletal Pain Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/musculoskeletal-pain-market
Trending Healthcare Reports By DelveInsight
Dysautonomia (Autonomic Dysfunction) Market
Dysautonomia (Autonomic Dysfunction) Market is set to evolve in the coming years owing to the rising awareness of the disease, the launch of emerging therapies, and incremental healthcare spending across the world. Globally, some of the key companies such as Celltex Therapeutics, Theravance Biopharma, PTC Therapeutics, and several others are diligently working in the Dysautonomia (Autonomic Dysfunction) Market.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/